Fig. 2From: Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levelsSystolic blood pressure during different treatment conditions in patients with a PAC above the median, and a PAC below the median. SBP is higher in the high PAC group in all treatment conditions, but the difference tends to decrease when treatment was intensified. Error bars represent standard error of the mean. SBP: systolic blood pressure; PAC: plasma aldosterone concentration; ARB: angiotensin receptor blocker (losartan 100Â mg/day); LS: dietary sodium restriction; HCT: hydrochlorothiazide (25Â mg/day)Back to article page